MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension
R. S. Friese(VA San Diego Healthcare System), Daniel T. O’Connor(Nova Southeastern University), Michael G. Ziegler(University of Tübingen), Sushil K. Mahata(University of California San Diego), Jiaur R. Gayen(Central Drug Research Institute), M. L. Jirout, Laurent Taupenot(University of California San Diego), Michal Pravenec(Czech Academy of Sciences), M. Cale, A. E. Altshuler(Bioengineering Center), Sucheta M. Vaingankar(Uppsala University), N. Biswas, C. Makena Hightower(University of California San Diego), José Pablo Miramontes‐González(University of California San Diego), Nitish R. Mahapatra(University of California San Diego), Nicholas J. Schork(Scripps Research Institute), Rany M. Salem(Human Longevity (United States)), Maïté Courel, Geert W. Schmid‐Schönbein(University of California San Diego), K. Zhang, H.-S. Kim(University of North Carolina at Chapel Hill)
Cited by 48
Related Papers
Genetic Dissection of Complex Traits
|Science|1994|3.5k
The Chromogranin–Secretogranin Family
|New England Journal of Medicine|2003|820
Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites
|Nature Genetics|2017|485
Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms
|New England Journal of Medicine|1986|484
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
|Journal of Clinical Investigation|1997|399